Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia
NCT01160679 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 231
Last updated 2011-08-18
Summary
This prospective, multi-center, 12 weeks naturalistic NIS trial will be conducted in 25 hospitals in naturalistic treatment setting. There will be no experimental component associated with this study and all observational activities have to be part of routine care visit: baseline (week 0), week 4 and week 12.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Sang-Woo Han, MD, PhD · Department of Psychiatry
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-08-31
- Primary Completion
- 2011-08-31
- Completion
- 2011-08-31
Countries
- South Korea
Study Locations
More Related Trials
-
Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective Disorder
NCT00892021 ·Status: WITHDRAWN ·Phase: PHASE1
-
Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm
NCT01016145 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics
NCT00986531 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Paliperidone Palmitate in Schizophrenia
NCT01860781 ·Status: COMPLETED ·Phase: PHASE4
-
Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
NCT00528905 ·Status: COMPLETED ·Phase: PHASE2
-
Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
NCT00932529 ·Status: COMPLETED ·Phase: PHASE4
-
Linear and Non-linear Analysis of EEG Changes in Schizophrenia After Atypical Antipsychotics Medication
NCT00698295 ·Status: UNKNOWN
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of GSK239512 in Schizophrenia
NCT01009060 ·Status: COMPLETED ·Phase: PHASE2
-
NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia
NCT00833456 ·Status: COMPLETED
-
Subjective Well Being of Schizophrenic Patients in Greece
NCT00857064 ·Status: COMPLETED
-
"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"
NCT03149107 ·Status: TERMINATED ·Phase: PHASE3
-
Quality of Life in Schizophrenic Patients
NCT00597168 ·Status: COMPLETED
-
A Trial to Assess the Antipsychotic Efficacy of ITI-007
NCT02282761 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate The Effects of RO5545965 in Participants With Negative Symptoms of Schizophrenia Treated With Antipsychotics
NCT02824055 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
NCT05958875 ·Status: RECRUITING ·Phase: PHASE4
-
Antipsychotic Discontinuation in High-risk Subjects
NCT01758887 ·Status: WITHDRAWN
-
A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia
NCT04510298 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Schizophrenia Patients' Clinical Study Experiences
NCT05948111 ·Status: NOT_YET_RECRUITING
-
A Retrospective NIS to Evaluate the Use of Seroquel XR and IR in the Clinical Practice of Outpatients With Schizophrenia
NCT01212575 ·Status: COMPLETED
-
The Study of Atypical Antipsychotics-induced Metabolic Disturbances
NCT00937755 ·Status: COMPLETED
-
Sertindole in Asian Patients With Schizophrenia
NCT00864045 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia
NCT02775864 ·Status: COMPLETED
-
Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117568 in Adults With Schizophrenia
NCT05545111 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of AVL-3288 in Schizophrenia Patients
NCT02978599 ·Status: COMPLETED ·Phase: PHASE1